Certain New Chemicals or Significant New Uses; Statements of Findings for October and November 2022, 6724-6725 [2023-02100]

Download as PDF 6724 Federal Register / Vol. 88, No. 21 / Wednesday, February 1, 2023 / Notices submitted using the methods in ADDRESSES and must be received by EPA on or before the closing date. These comments will become part of the docket for the pesticides included in the Tables in Unit IV. Comments received after the close of the comment period will be marked ‘‘late.’’ EPA is not required to consider these late comments. The Agency will carefully consider all comments received by the closing date and may provide a ‘‘Response to Comments Memorandum’’ in the docket. The interim or final registration review decision will explain the effect that any comments had on the decision and provide the Agency’s response to significant comments. Background on the registration review program is provided at: https:// www.epa.gov/pesticide-reevaluation. Authority: 7 U.S.C. 136 et seq. Dated: January 23, 2023. Mary Elissa Reaves, Director, Pesticide Re-Evaluation Division, Office of Pesticide Programs. [FR Doc. 2023–02078 Filed 1–31–23; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPPT–2022–0116; FRL–9412–18– OCSPP] Certain New Chemicals or Significant New Uses; Statements of Findings for October and November 2022 Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA submissions when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from October 1, 2022 to November 30, 2022. ADDRESSES: The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2022–0116, is available online at https:// www.regulations.gov or in-person at the Office of Pollution Prevention and lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 21:04 Jan 31, 2023 Jkt 259001 Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For technical information contact: Rebecca Edelstein, New Chemical Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–1667 email address: edelstein.rebecca@ epa.gov. For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUPPLEMENTARY INFORMATION: 5(a) when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to PMNs, MCANs, and SNUNs submitted to EPA under TSCA section 5. Anyone who plans to manufacture (which includes import) a new chemical substance for a non-exempt commercial purpose and any manufacturer or processor wishing to engage in a use of a chemical substance designated by EPA as a significant new use must submit a notice to EPA at least 90 days before commencing manufacture of the new chemical substance or before engaging in the significant new use. The submitter of a notice to EPA for which EPA has made a finding of ‘‘not likely to present an unreasonable risk of injury to health or the environment’’ may commence manufacture of the chemical substance or manufacture or processing for the significant new use notwithstanding any remaining portion of the applicable review period. I. Executive Summary II. Statements of Findings Under TSCA Section 5(a)(3)(C) In this unit, EPA provides the following information (to the extent that such information is not claimed as Confidential Business Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this period, EPA has made findings under TSCA section 5(a)(3)(C) that the new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment: The following list provides the EPA case number assigned to the TSCA section 5(a) submission and the chemical identity (generic name if the specific name is claimed as CBI). • J–22–0017, J–22–0018, Microorganisms transformed to express an enzyme (Generic Name). • J–22–0021, Genetically modified microorganism for the production of a chemical substance (Generic Name). • P–21–0174, Carbonic acid, ester, polymer with alkanediol (C=4,5) (Generic Name). To access EPA’s decision document describing the basis of the ‘‘not likely to present an unreasonable risk’’ finding made by EPA under TSCA section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/newchemicals-under-toxic-substances- A. Does this action apply to me? This action provides information that is directed to the public in general. B. What action is the Agency taking? This document lists the statements of findings made by EPA after review of submissions under TSCA section 5(a) that certain new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment. This document presents statements of findings made by EPA during the reporting period. C. What is the Agency’s authority for taking this action? TSCA section 5(a)(3) requires EPA to review a submission under TSCA section 5(a) and make one of several specific findings pertaining to whether the substance may present unreasonable risk of injury to health or the environment. Among those potential findings is that the chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment per TSCA Section 5(a)(3)(C). TSCA section 5(g) requires EPA to publish in the Federal Register a statement of its findings after its review of a submission under TSCA section PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 D. Does this action have any incremental economic impacts or paperwork burdens? No. E:\FR\FM\01FEN1.SGM 01FEN1 Federal Register / Vol. 88, No. 21 / Wednesday, February 1, 2023 / Notices control-act-tsca/chemicals-determinednot-likely. Authority: 15 U.S.C. 2601 et seq. Dated: January 25, 2023. Madison Le, Director, New Chemicals Division, Office of Pollution Prevention and Toxics. [FR Doc. 2023–02100 Filed 1–31–23; 8:45 am] [IB Docket No. 16–185; DA 23–72; FR ID 125216] World Radiocommunication Conference Advisory Committee Schedules Its Seventh Meeting on April 11, 2023 BILLING CODE 6560–50–P AGENCY: FARM CREDIT SYSTEM INSURANCE CORPORATION SUMMARY: Federal Communications Commission. ACTION: Notice. Board of Directors Meeting Notice of the forthcoming regular meeting of the Board of Directors of the Farm Credit System Insurance Corporation (FCSIC), is hereby given in accordance with the provisions of the Bylaws of the FCSIC. SUMMARY: DATES: 10 a.m., Wednesday, February 8, 2023. You may observe the open portions of this meeting in person at 1501 Farm Credit Drive, McLean, Virginia 22102–5090, or virtually. If you would like to virtually attend, at least 24 hours in advance, visit FCSIC.gov, select ‘‘News & Events,’’ then select ‘‘Board Meetings.’’ From there, access the linked ‘‘Instructions for board meeting visitors’’ and complete the described registration process. ADDRESSES: If you need more information or assistance for accessibility reasons, or have questions, contact Ashley Waldron, Secretary to the Board. Telephone: 703– 883–4009. TTY: 703–883–4056. FOR FURTHER INFORMATION CONTACT: Parts of this meeting will be open to the public. The rest of the meeting will be closed to the public. The following matters will be considered: SUPPLEMENTARY INFORMATION: Portions Open to the Public • Approval of December 7, 2022, Minutes • Review and Setting of Insurance Premium Accrual Rates Portions Closed to the Public lotter on DSK11XQN23PROD with NOTICES1 FEDERAL COMMUNICATIONS COMMISSION • Annual Report on Contracts • Annual Report on Whistleblower Activity Ashley Waldron, Secretary to the Board. [FR Doc. 2023–02004 Filed 1–31–23; 8:45 am] BILLING CODE 6705–01–P VerDate Sep<11>2014 21:04 Jan 31, 2023 Jkt 259001 In accordance with the Federal Advisory Committee Act, this notice advises interested persons that the seventh meeting of the World Radiocommunication Conference Advisory Committee (WAC or Advisory Committee) will be held on April 11, 2023 at the Federal Communications Commission (FCC). The meeting is open to the public. This seventh Advisory Committee meeting will consider status reports and recommendations from its Informal Working Groups (IWG–1, IWG–2, IWG–3, and IWG–4) concerning preparation for the 2023 World Radiocommunication Conference (WRC–23). The Commission’s WRC–23 website (www.fcc.gov/wrc-23) contains the latest information on the IWG and WAC meeting agendas and audience participation information, all scheduled meeting dates and updates, and Advisory Committee matters. Comments may be presented at the Advisory Committee meeting or in advance of the meeting by email to: WRC-23@fcc.gov. DATES: Tuesday, April 11, 2023 at 11 a.m. ADDRESSES: Federal Communications Commission, 45 L Street NE, Room 1.200, Washington, DC 20002. FOR FURTHER INFORMATION CONTACT: Dante Ibarra, Designated Federal Official, World Radiocommunication Conference Advisory Committee, FCC International Bureau, Global Strategy and Negotiation Division, at Dante.Ibarra@fcc.gov, (202)–418–0610 or WRC-23@fcc.gov. SUPPLEMENTARY INFORMATION: The FCC established the Advisory Committee to provide advice, technical support and recommendations relating to the preparation of United States proposals and positions for the 2023 World Radiocommunication Conference (WRC–23). In accordance with the Federal Advisory Committee Act, Public Law 92–463, as amended, this notice advises interested persons of the seventh meeting of the Advisory Committee. The Commission’s WRC–23 website (www.fcc.gov/wrc-23) contains the latest PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 6725 information on the IWG and WAC meeting agendas and audience participation information, all scheduled meeting dates and updates, and WRC– 23 Advisory Committee matters. The seventh Advisory Committee meeting will be broadcast live with open captioning over the internet from the FCC Live web page at www.fcc.gov/live. There will be audience participation available; send live questions to livequestions@fcc.gov only during this meeting. Reasonable accommodations for people with disabilities are available upon request. Include a description of the accommodation you will need and tell us how to contact you if we need more information. Make your request as early as possible. Last minute requests will be accepted, but may be impossible to fill. Send an email to: FCC504@ fcc.gov or call the Consumer and Governmental Affairs Bureau at 202– 418–0530 (voice). The proposed agenda for the seventh WAC meeting is as follows: Agenda Seventh Meeting of the World Radiocommunication Conference Advisory Committee Federal Communications Commission Tuesday, April 11, 2023; 11 a.m. 1. Opening Remarks 2. Approval of Agenda 3. Approval of the Minutes of the Sixth Meeting 4. IWG Reports and Consideration Documents 5. Future Meetings 6. Other Business Federal Communications Commission. Nese Guendelsberger, Deputy Bureau Chief, International Bureau. [FR Doc. 2023–02111 Filed 1–31–23; 8:45 am] BILLING CODE 6712–01–P FEDERAL COMMUNICATIONS COMMISSION [MB Docket No. 12–108; DA 23–66; FR ID 124910] Closed Captioning Display Settings Proposal Federal Communications Commission. ACTION: Notice, request for comments. AGENCY: In this document, the Media Bureau of the Federal Communications Commission (Commission) seeks comment on a proposal in the record of this proceeding that when the Commission is determining whether specific closed captioning display SUMMARY: E:\FR\FM\01FEN1.SGM 01FEN1

Agencies

[Federal Register Volume 88, Number 21 (Wednesday, February 1, 2023)]
[Notices]
[Pages 6724-6725]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02100]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2022-0116; FRL-9412-18-OCSPP]


Certain New Chemicals or Significant New Uses; Statements of 
Findings for October and November 2022

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to 
publish in the Federal Register a statement of its findings after its 
review of certain TSCA submissions when EPA makes a finding that a new 
chemical substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment. Such 
statements apply to premanufacture notices (PMNs), microbial commercial 
activity notices (MCANs), and significant new use notices (SNUNs) 
submitted to EPA under TSCA. This document presents statements of 
findings made by EPA on such submissions during the period from October 
1, 2022 to November 30, 2022.

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPPT-2022-0116, is available online 
at https://www.regulations.gov or in-person at the Office of Pollution 
Prevention and Toxics Docket (OPPT Docket), Environmental Protection 
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., 
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading 
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, 
excluding legal holidays. The telephone number for the Public Reading 
Room is (202) 566-1744, and the telephone number for the OPPT Docket is 
(202) 566-0280. For the latest status information on EPA/DC services 
and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: 
    For technical information contact: Rebecca Edelstein, New Chemical 
Division (7405M), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460-0001; telephone number: (202) 564-1667 email address: 
[email protected].
    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION:

I. Executive Summary

A. Does this action apply to me?

    This action provides information that is directed to the public in 
general.

B. What action is the Agency taking?

    This document lists the statements of findings made by EPA after 
review of submissions under TSCA section 5(a) that certain new chemical 
substances or significant new uses are not likely to present an 
unreasonable risk of injury to health or the environment. This document 
presents statements of findings made by EPA during the reporting 
period.

C. What is the Agency's authority for taking this action?

    TSCA section 5(a)(3) requires EPA to review a submission under TSCA 
section 5(a) and make one of several specific findings pertaining to 
whether the substance may present unreasonable risk of injury to health 
or the environment. Among those potential findings is that the chemical 
substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment per TSCA 
Section 5(a)(3)(C).
    TSCA section 5(g) requires EPA to publish in the Federal Register a 
statement of its findings after its review of a submission under TSCA 
section 5(a) when EPA makes a finding that a new chemical substance or 
significant new use is not likely to present an unreasonable risk of 
injury to health or the environment. Such statements apply to PMNs, 
MCANs, and SNUNs submitted to EPA under TSCA section 5.
    Anyone who plans to manufacture (which includes import) a new 
chemical substance for a non-exempt commercial purpose and any 
manufacturer or processor wishing to engage in a use of a chemical 
substance designated by EPA as a significant new use must submit a 
notice to EPA at least 90 days before commencing manufacture of the new 
chemical substance or before engaging in the significant new use.
    The submitter of a notice to EPA for which EPA has made a finding 
of ``not likely to present an unreasonable risk of injury to health or 
the environment'' may commence manufacture of the chemical substance or 
manufacture or processing for the significant new use notwithstanding 
any remaining portion of the applicable review period.

D. Does this action have any incremental economic impacts or paperwork 
burdens?

    No.

II. Statements of Findings Under TSCA Section 5(a)(3)(C)

    In this unit, EPA provides the following information (to the extent 
that such information is not claimed as Confidential Business 
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this 
period, EPA has made findings under TSCA section 5(a)(3)(C) that the 
new chemical substances or significant new uses are not likely to 
present an unreasonable risk of injury to health or the environment:
    The following list provides the EPA case number assigned to the 
TSCA section 5(a) submission and the chemical identity (generic name if 
the specific name is claimed as CBI).
     J-22-0017, J-22-0018, Microorganisms transformed to 
express an enzyme (Generic Name).
     J-22-0021, Genetically modified microorganism for the 
production of a chemical substance (Generic Name).
     P-21-0174, Carbonic acid, ester, polymer with alkanediol 
(C=4,5) (Generic Name).
    To access EPA's decision document describing the basis of the ``not 
likely to present an unreasonable risk'' finding made by EPA under TSCA 
section 5(a)(3)(C), look up the specific case number at https://
www.epa.gov/new-chemicals-under-toxic-substances-

[[Page 6725]]

control-act-tsca/chemicals-determined-not-likely.
    Authority: 15 U.S.C. 2601 et seq.

    Dated: January 25, 2023.
Madison Le,
Director, New Chemicals Division, Office of Pollution Prevention and 
Toxics.
[FR Doc. 2023-02100 Filed 1-31-23; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.